Explore opportunities

Search by company name (Bolden, Pax, OncoLux, Nabsys), asset id, or title. Each card links to a full dossier with cited evidence.

Loading filters…

Tier Bip_oncolux_lumis
LUMIS optical theranostics — intraoperative see-and-treat oncology

See malignant margins and treat in the same OR workflow—AI-guided optical theranostics.

RILSH attraction award + Ocean State Labs + Mayo know-how—medtech growth, not university OTL.

Entity: OncoLuxPatents: 3Stage: clinical validation
US20260083330A1US20250076201A1US20240310617A1Source
Open dossier
Tier APatent gapgap_smurf2_oncology
SMURF2–HIF1α oncology

HIF-pathway oncology with Welireg-scale commercial proof—harvest El-Deiry estate.

R01CA173453 + SMURF-Tx Providence—Slater seed after biomarker PoC.

Entity: SMURF-TherapeuticsPatents: 3Stage: preclinical grant
WO2024192252A1US20230183356A1US20230219957A1R01CA173453PMID 39697237PMID 34611473
Open dossier
Research synthesis from public sources (NIH RePORTER, ClinicalTrials.gov, PubMed, USPTO, company press). Not investment advice, legal opinion, or clinical guidance. Verify cap tables, license chains, and trial status in data rooms before term sheets.